BioNeutra Global Corporation
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, Europ… Read more
BioNeutra Global Corporation (BGACF) - Net Assets
Latest net assets as of September 2024: $-8.23 Million USD
Based on the latest financial reports, BioNeutra Global Corporation (BGACF) has net assets worth $-8.23 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.57 Million) and total liabilities ($21.81 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-8.23 Million |
| % of Total Assets | -60.64% |
| Annual Growth Rate | N/A |
| 5-Year Change | -230.33% |
| 10-Year Change | -158.23% |
| Growth Volatility | 170.11 |
BioNeutra Global Corporation - Net Assets Trend (1997–2023)
This chart illustrates how BioNeutra Global Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BioNeutra Global Corporation (1997–2023)
The table below shows the annual net assets of BioNeutra Global Corporation from 1997 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-6.19 Million | -64.92% |
| 2022-12-31 | $-3.76 Million | -263.28% |
| 2021-12-31 | $-1.03 Million | -247.50% |
| 2020-12-31 | $700.92K | -85.25% |
| 2019-12-31 | $4.75 Million | -73.68% |
| 2018-12-31 | $18.06 Million | +29.39% |
| 2017-12-31 | $13.96 Million | -11.57% |
| 2016-12-31 | $15.78 Million | +3.93% |
| 2015-12-31 | $15.19 Million | +42.76% |
| 2014-12-31 | $10.64 Million | +452.50% |
| 2013-12-31 | $1.93 Million | +604.74% |
| 2012-12-31 | $273.21K | -14.31% |
| 2011-12-31 | $318.85K | -33.21% |
| 2010-12-31 | $477.40K | -21.37% |
| 2009-12-31 | $607.19K | +216.85% |
| 2008-12-31 | $-519.63K | -156.59% |
| 2007-12-31 | $918.18K | -20.03% |
| 2006-12-31 | $1.15 Million | -5.33% |
| 2005-12-31 | $1.21 Million | -1.90% |
| 2004-12-31 | $1.24 Million | +2.18% |
| 2003-12-31 | $1.21 Million | +32.38% |
| 2002-12-31 | $913.84K | -8.45% |
| 2001-12-31 | $998.23K | +19.76% |
| 2000-12-31 | $833.52K | +66.70% |
| 1999-12-31 | $500.00K | 0.00% |
| 1998-12-31 | $500.00K | 0.00% |
| 1997-12-31 | $500.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to BioNeutra Global Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1595306900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.55 Million | % |
| Other Comprehensive Income | $499.64K | % |
| Other Components | $1.81 Million | % |
| Total Equity | $-6.19 Million | 100.00% |
BioNeutra Global Corporation Competitors by Market Cap
The table below lists competitors of BioNeutra Global Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Structured Products Corp Corts Tr for Peco Energy Cap Tr III GIC
NYSE:KTH
|
$260.26K |
|
H&R.BLOCK (HRB.SG)
STU:HRB
|
$260.28K |
|
Cann-Is Capital Corp
V:NIS-P
|
$260.42K |
|
ANGLO AMERICAN - Dusseldorf Stock Exchang
DU:NGLB
|
$260.48K |
|
Regent Pacific Properties Inc
V:RPP
|
$260.10K |
|
ChemX Materials Ltd
AU:CMX
|
$260.10K |
|
General Shopping e Outlets do Brasil S.A.
SA:GSHP3
|
$259.78K |
|
Vivid Seats Inc. Warrant
NASDAQ:SEATW
|
$259.46K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BioNeutra Global Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -3,755,748 to -6,193,962, a change of -2,438,214.
- Net loss of 2,108,000 reduced equity.
- Other comprehensive income decreased equity by 330,635.
- Other factors increased equity by 421.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.11 Million | -34.03% |
| Other Comprehensive Income | $-330.63K | -5.34% |
| Other Changes | $421.00 | +0.01% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares BioNeutra Global Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-12-31 | $0.10 | $0.07 | x |
| 1998-12-31 | $0.10 | $0.07 | x |
| 1999-12-31 | $0.07 | $0.07 | x |
| 2000-12-31 | $0.10 | $0.07 | x |
| 2001-12-31 | $0.08 | $0.07 | x |
| 2002-12-31 | $0.06 | $0.07 | x |
| 2003-12-31 | $0.09 | $0.07 | x |
| 2004-12-31 | $0.08 | $0.07 | x |
| 2005-12-31 | $0.08 | $0.07 | x |
| 2006-12-31 | $0.08 | $0.07 | x |
| 2007-12-31 | $0.05 | $0.07 | x |
| 2008-12-31 | $-0.05 | $0.07 | x |
| 2009-12-31 | $0.05 | $0.07 | x |
| 2010-12-31 | $0.04 | $0.07 | x |
| 2011-12-31 | $0.03 | $0.07 | x |
| 2012-12-31 | $0.02 | $0.07 | x |
| 2013-12-31 | $0.16 | $0.07 | x |
| 2014-12-31 | $0.44 | $0.07 | x |
| 2015-12-31 | $0.33 | $0.07 | x |
| 2016-12-31 | $0.34 | $0.07 | x |
| 2017-12-31 | $0.30 | $0.07 | x |
| 2018-12-31 | $0.39 | $0.07 | x |
| 2019-12-31 | $0.10 | $0.07 | x |
| 2020-12-31 | $0.02 | $0.07 | x |
| 2021-12-31 | $-0.02 | $0.07 | x |
| 2022-12-31 | $-0.08 | $0.07 | x |
| 2023-12-31 | $-0.13 | $0.07 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BioNeutra Global Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -18.52%
- • Asset Turnover: 0.72x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-29.12%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | -20.00% | -10.00% | 1.43x | 1.40x | $-150.00K |
| 1998 | -40.00% | -200.00% | 0.11x | 1.80x | $-250.00K |
| 2000 | -5.24% | -4.00% | 0.51x | 2.57x | $-127.02K |
| 2001 | -11.07% | -3.82% | 0.79x | 3.69x | $-176.50K |
| 2002 | -27.86% | -4.92% | 0.86x | 6.59x | $-236.46K |
| 2003 | 6.64% | 1.28% | 1.36x | 3.80x | $-29.39K |
| 2004 | 1.65% | 0.23% | 1.02x | 7.06x | $-70.62K |
| 2005 | 7.63% | 1.22% | 0.82x | 7.65x | $-19.87K |
| 2006 | -3.18% | -1.03% | 0.69x | 4.44x | $-101.81K |
| 2007 | -37.77% | -11.44% | 0.88x | 3.73x | $-259.27K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.14 Million |
| 2009 | 156.17% | 0.00% | 0.00x | 1.29x | $887.54K |
| 2010 | -27.19% | 0.00% | 0.00x | 1.09x | $-177.52K |
| 2011 | -49.73% | 0.00% | 0.00x | 1.41x | $-190.44K |
| 2012 | -16.71% | -2.10% | 7.49x | 1.06x | $-72.96K |
| 2013 | 35.26% | 8.96% | 1.23x | 3.21x | $486.31K |
| 2014 | 48.04% | 32.61% | 1.13x | 1.30x | $4.05 Million |
| 2015 | 1.18% | 1.12% | 0.60x | 1.76x | $-1.34 Million |
| 2016 | 6.84% | 4.16% | 0.71x | 2.32x | $-498.34K |
| 2017 | -8.32% | -3.61% | 1.04x | 2.22x | $-2.56 Million |
| 2018 | 17.18% | 8.23% | 0.94x | 2.21x | $1.30 Million |
| 2019 | -261.82% | -33.00% | 1.11x | 7.16x | $-12.92 Million |
| 2020 | -528.88% | -15.37% | 1.02x | 33.78x | $-3.78 Million |
| 2021 | 0.00% | -18.38% | 0.73x | 0.00x | $-2.73 Million |
| 2022 | 0.00% | -21.81% | 0.68x | 0.00x | $-2.55 Million |
| 2023 | 0.00% | -18.52% | 0.72x | 0.00x | $-1.49 Million |
Industry Comparison
This section compares BioNeutra Global Corporation's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $5,681,533,529
- Average return on equity (ROE) among peers: 0.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BioNeutra Global Corporation (BGACF) | $-8.23 Million | -20.00% | N/A | $260.11K |
| Above Food Ingredients Inc. Common Stock (ABVE) | $30.90K | -3.31% | 7.66x | $18.76 Million |
| The a2 Milk Company Limited (ACOPF) | $7.27 Million | -30.19% | 0.14x | $3.91 Billion |
| Ayujoy Herbals Ltd (AJOY) | $22.20 Million | 29.29% | 0.00x | $95.71 |
| Alfa S.A.B. de C.V (ALFFF) | $53.35 Billion | 7.36% | 3.80x | $2.16 Billion |
| Amincor Inc (AMNCB) | $34.44 Million | -63.76% | 0.81x | $2.24K |
| Armanino Foods New (AMNF) | $21.40 Million | 30.30% | 0.33x | $72.33K |
| Amira Nature Foods Ltd (ANFIF) | $303.22 Million | 8.27% | 0.89x | $128.79 |
| AAK AB (publ.) (ARHUF) | $2.44 Billion | 12.85% | 2.63x | $5.07 Billion |
| Artisan Consumer Goods Inc (ARRT) | $-326.75K | 0.00% | 0.00x | $279.39K |
| ARYZTA AG (ARZTF) | $632.10 Million | 9.58% | 2.04x | $53.13 Million |